Diuretic effects of medetomidine compared with xylazine in healthy dogs.
This study aimed to investigate and compare the effects of medetomidine and xylazine on diuretic and hormonal variables in healthy dogs. Five dogs, used in each of 11 groups, were injected intramuscularly with physiological saline solution (control), 5, 10, 20, 40, and 80 microg/kg of medetomidine, and 0.25, 0.5, 1, 2, and 4 mg/kg of xylazine. Urine and blood samples were taken 11 times over 24 h. Both medetomidine and xylazine increased urine production in a dose-dependent manner up to 4 h after injection, but the increase was much less with medetomidine than with xylazine at the tested doses. Urine specific gravity, pH, osmolality, and concentrations of creatinine, sodium, potassium, chloride, and arginine vasopressin (AVP) were decreased in a dose-dependent manner with both medetomidine and xylazine. Plasma osmolality and concentrations of sodium, potassium, and chloride were increased significantly with both drugs. Total amounts of urine AVP excreted and plasma AVP concentrations were significantly decreased by higher doses of medetomidine but were not significantly decreased by xylazine. Higher doses of both drugs significantly increased the plasma concentration of atrial natriuretic peptide (ANP), but the effect was greater with medetomidine than with xylazine. The results revealed that both drugs induce a profound diuresis, but medetomidine's effect is less dose-dependent than xylazine's effect. Although changes in plasma concentrations of AVP and ANP may partially influence the diuresis induced by medetomidine, other factors may be involved in the mechanism of the diuretic response to both drugs. Thus, both agents can be used clinically for transient but effective diuresis accompanied by sedation.
Talukder
Md Hasanuzzaman
MH
Laboratory of Veterinary Internal Medicine, Department of Veterinary Medicine, Faculty of Agriculture, Tottori University, Tottori, Japan.
Hikasa
Yoshiaki
Y
D000818:Animals; D019540:Area Under Curve; D001127:Arginine Vasopressin / Q000097:blood / Q000652:urine*; D009320:Atrial Natriuretic Factor / Q000097:blood / Q000652:urine*; D001774:Blood Chemical Analysis / Q000662:veterinary; D004231:Diuresis / Q000187:drug effects; D004285:Dogs / Q000378:metabolism* / Q000652:urine; D004305:Dose-Response Relationship, Drug; D008297:Male; D020926:Medetomidine / Q000008:administration & dosage*; D016482:Urinalysis / Q000662:veterinary; D014991:Xylazine / Q000008:administration & dosage*
D001127:Arginine Vasopressin; D014991:Xylazine; D009320:Atrial Natriuretic Factor; D020926:Medetomidine